
European "shield" against colorectal cancer based on novel screening methods | Funded by @HorizonEU, grant agreement 101097036 | Views of the project owner only
Athens, Greece
Joined December 2022
- Tweets328
- Following658
- Followers274
- Likes249
Pinned Tweet
👋Hello and welcome to ONCOSCREEN!
@oncoscreen seeks to develop new methods and technologies for colorectal cancer screening and its early detection.
Below is a thread🧵outlining all you need to know about #ONCOSCREEN and what the project involves👇
🔎 Meet #ONCOSCREEN partner URIOJA 🇪🇸
The team will lead health economics analysis of the project’s trials, evaluating innovative screening solutions and exploring financial schemes that support collaboration between public and private healthcare.
youtu.be/9spxPQJfEFc
How can research translate into game-changing innovation in clinical practice? 🔬
Join #ONCOSCREEN, #DIOPTRA , #SANGUINE, #LUCIA, #MammoScreen & #PANCAID at the Prevention & Early Detection Screening Cluster Open Day in Liège 🇧🇪 on 26 Nov.
📍 Register: ti.to/dioptra/eu-mission-can…
Day 2 of the #ONCOSCREEN Plenary in Graz! 🇦🇹
Today we’re focusing on clinical trials, holistic evaluation and living guidelines, before closing with a policy workshop exploring the project’s potential impact on future EU policy for CRC screening & prevention. 📜
#MissionCancer
This afternoon #ONCOSCREEN, partners are focusing on advancing CRC diagnostics and developing intelligent tools for citizens, clinicians & policymakers.
We’ll also hold our 3rd Exploitation & IPR Workshop, exploring how we can create lasting impact beyond the project.
Guten Morgen aus Graz! 🇦🇹
The 3rd #ONCOSCREEN Plenary is underway at the Medical University of Graz.
After an insightful tour of the Institute of Pathology and Biobank, we’re getting into updates on technical management, evidence-based studies and end-user requirements.🔬
📣 The ONCOSCREEN consortium will host its next plenary meeting on 24–25 September!
Partners will review progress, share insights and strengthen collaboration as we work towards improving colorectal cancer screening and early detection across Europe. 🔬
ONCOSCREEN researchers have developed a standardised framework for creating “tissue maps” from Whole Slide Images, making it easier to search, organise and build datasets for AI-assisted pathology and cancer research.
📰 Read more: oncoscreen.health/2026/09/08…
Could breath help detect colorectal cancer earlier?
At #IEEEEMBC2026, ONCOSCREEN showcased its AI-powered breathomics approach, using volatile organic compounds (VOCs) to explore new possibilities for non-invasive colorectal cancer screening.
For more: oncoscreen.health/2026/08/05…
🎥 How is ONCOSCREEN connecting health data to advance colorectal cancer research?
Watch our latest demo on semantic integration and federated data management—enabling secure, interoperable data sharing while preserving institutional data ownership.
🎥 ow.ly/wmLZ50Zt4Ty
🎥 Partner Spotlight: ICCS
As ONCOSCREEN's technical coordinator, ICCS is developing trustworthy AI, leading system architecture and ensuring seamless integration across the project's innovative colorectal cancer screening solutions.
youtu.be/HR_gxvrnexQ?si=LUhb…
🩵 Are you 18+ with lived experience of cancer? Your voice matters.
Take Youth Cancer Europe's YARN survey on social connections and help shape future support for young people across Europe.
📝 docs.google.com/forms/d/e/1F…
#ONCOSCREEN #YARN #MissionCancer
🎥 Partner Spotlight: URIOJA
The Universidad de La Rioja is leading the health economics analysis of ONCOSCREEN, helping evaluate new colorectal cancer screening solutions and sustainable financing models for healthcare systems.
youtu.be/9spxPQJfEFce
How does ONCOSCREEN connect concepts, metadata, and federated data access?
Our latest video demonstration walks through the Conceptual Model, the role of KGen, and the implementation of the Virtual Data Lake.
🎥 Watch the video on the blog:oncoscreen.health/2026/06/04…
🎥 Partner Spotlight: UKSH
Led by Prof. Dr. Jens Marquardt, UKSH will host ONCOSCREEN clinical studies in Lübeck and contribute to colorectal cancer biomarker research, helping advance early detection and diagnosis.
youtu.be/LLF_zNSWmLw
#ONCOSCREEN #MissionCancer
🩺 ONCO-CLIDE is helping clinicians navigate colorectal cancer diagnosis with AI-driven decision support and integrated patient data, supporting earlier, more personalised care across Europe.
Read more: oncoscreen.health/2026/05/07…
#ONCOSCREEN #HorizonEurope
🎥 The Portuguese Oncology Institute of Porto is advancing colorectal cancer care through research, innovation and precision oncology.
Find out more about their role on the #ONCOSCREEN Project: youtu.be/ok50fYeD-8E
🎥 VITO is leading intelligent analytics for ONCO-EVIDA—helping policymakers turn complex colorectal cancer data into clear, actionable insights.
A step forward for data-driven, equitable cancer care in Europe.
Watch: youtu.be/G3WGczfv1Uc
🌍On World Health Day, ONCOSCREEN is highlighting the importance of prevention and early detection in improving health outcomes worldwide.
By using AI-driven screening and data-led insights, we aim to support clinicians, enable earlier cancer detection, and improve patient care.
Stakeholder Spotlight Miniseries 🩺
Screening can catch precancerous polyps or early colorectal cancer before symptoms appear.
Find out more from Prof. Juozas Kupčinskas , Vice Rector for Research at Lithuanian University of Health Sciences: oncoscreen.health/2026/03/10…
🎥 Partner Spotlight: University Medical Center Mainz
A key clinical partner in ONCOSCREEN, leading clinical studies and helping validate new approaches to earlier colorectal cancer detection.
Watch the video: youtu.be/fLaokiEKtgY












